Cameron John Reynolds - President and CEO, Director at Volitionrx Ltd

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Cameron John Reynolds - trading volume in the past year for Volitionrx Ltd

Holdings reported by Cameron John Reynolds for Volitionrx Ltd

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,844,850 $1.61 M $0.87 Jun 1, 2024 Direct
Common Stock 1,007,718 $877 K $0.87 Jun 1, 2024 By Concord International, Inc.
Common Stock 34,076 $29.6 K $0.87 Jun 1, 2024 By Spouse

Transactions reported by Cameron John Reynolds for Volitionrx Ltd

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership